Established in 1991, GF Securities was one of the first, full-service investment banks in China. GF Securities has been ranked among the top ten Investment banks for a consecutive 23 years. GF Securities, dual listed in Shenzhen and Hong Kong, focuses on serving Chinese quality SMEs and affluent clients and the company is an integrated-service broker with an industry-leading 264 branches.
GF XINDE Investment Management
GF XINDE Investment Management Co., Ltd. has more than 50 life sciences investment professionals in the business of venture capital, investment bank and industry research, and is a top VC firm in China. GF XINDE has over 25 billion RMB under management, and has invested in more than 200 companies.
Bay City Capital
Bay City Capital is headquartered in San Francisco with more than 15 investment professionals in the field of life sciences and outstanding scientific advisory board. BCC is a leading life sciences VC firm with deep domain and operational experience in the investment of global biotech and healthcare companies. There are more than 100 life Sciences companies in the portfolio and the AUM of BCC is more than 1.3 billion USD.
ChinaBio® Group is an investment, consulting and advisory firm founded in Shanghai in 2007. ChinaBio helps US, European and Asia-Pacific life science companies achieve success in China through fund raising, partnering and acquisition activities. ChinaBio has also organized over 30 investment and partnering conferences in China, and publishes ChinaBio Today, the most widely read source of news and insights on China's life science industry.